Fund managers go global for top Sohn conference stock picks over Aussie companies

SH&M had before Friday’s event made more than $40m in collective donations to medical research.

Fund managers go global for top Sohn conference stock picks over Aussie companies

November 18, 2022
SH&M had before Friday’s event made more than $40m in collective donations to medical research.
Read Transcript

AMP’s board must focus on breaking up and selling parts of the 173-year group in an orderly way, to avoid repeating “bad old habits” and making ill-fated acquisitions.

That’s the view of Samuel Terry Asset Management founder Fred Woollard who on Friday outed AMP as his top stock pick at the Sohn Hearts & Minds investment conference in Hobart.

“The sum of the parts are worth substantially more than its market capitalisation,” he said, delivering the value manager’s first presentation to the conference, which is in its seventh year.

Mr Woollard said AMP’s shares were worth at least $2 and up to $2.17 on his model, versus its current price of $1.285.

He outlined that asset sales meant AMP would soon have surplus cash of more than $2bn, it owned a profitable bank, wealth business in New Zealand while its platform business was worth about $1bn. Samuel Terry’s AMP model put the value of its three international minority stakes at least $685m or up to $1bn.

“AMP‘s mix of assets do not belong together. There are no synergies between an Australian and New Zealand wealth manager and a minority stake-owned Chinese pension manager,” Mr Woollard said. “Keeping these assets together is costing AMP shareholders lots of money. Shrinking and simplifying AMP should not be rushed, it should be done in an orderly and considerate (manner).”

While AMP was one of four local stocks among the best picks at the Sohn conference, it was international stocks – including those across laboratory services, semiconductors and retail – that dominated the top picks.

Cooper Investors’ founder and investment chief Peter Cooper named Eurofins at his top pick for this year. The Luxembourg-headquartered group provides lab testing and support services to the pharmaceutical, food, environmental industries, among others.

“One of the attributes of the service is it’s really cheap,” Mr Cooper said. He noted Eurofins conducted 450 million tests per annum at a cost of about $15 per test for things such as food safety.

“Every year in this industry of testing, volumes are going up 5 per cent a year,” he said.

“It’s a terrific dynamic in a mission-critical product.”

Peter Cooper at Sohn Hearts & Minds Investment Leaders Conference in Hobart.
Peter Cooper at Sohn Hearts & Minds Investment Leaders Conference in Hobart.

Mr Cooper – whose firm manages $10.5bn – also highlighted Eurofins was delivering returns of 26 per cent per year for shareholders, surpassing returns of local stocks CSL and Macquarie Group.

“We think this thing’s worth €100 ($155) a share,” he said. Eurofins last traded at €66.50.

Claremont Global portfolio manager Bob Desmond picked sportswear giant Nike as his top pick. Just buy it, he quipped.

He said the company was “hoovering up data” that allowed it to innovate and deliver the right product to consumers, and had targeted having 60 per cent of sales made direct to consumers by 2025. Mr Desmond estimated Nike would get a 100 basis point tailwind from bypassing retailers.

The Sohn conference, held annually, had before Friday’s event made more than $40m in collective donations to medical research. It applies the stock picks made by fund managers in an investment portfolio. The listed fund’s latest performance update noted 8.3 per cent returns per annum since inception in November 2018, but it cited “disappointing” underperformance in October. Among its top 10 holdings are Alphabet, BHP, Visa and Zillow.

Tribeca Investment Partners portfolio manager Jun Bei Liu opted for a Chinese retail stock for her best pick. China Duty Free Group – the biggest duty free operator in the world – offered a “phenomenal opportunity” due to an expected “explosion of (Chinese) tourist numbers” in coming years as the pandemic receded, she said. Ms Liu noted growth would be delivered as the company pursued geographic expansion.

Tribeca Investment Partners portfolio manager Jun Bei Liu opted for a Chinese retail stock for her best pick. Picture: Jane Dempster
Tribeca Investment Partners portfolio manager Jun Bei Liu opted for a Chinese retail stock for her best pick. Picture: Jane Dempster

Munro Partners founder and investment chief Nick Griffin highlighted Dutch-listed company ASML as his stock pick.

ASML produces lithography tools for the production of semiconductors and Mr Griffin said the group was “a monopoly” in the high-end part of the market selling its products to companies including Samsung and Intel.

“We see ASML’s (earnings-per-share) growing from €14 today to €41 by 2025 … we expect their earnings to accelerate,” Mr Griffin said, noting the stock had fallen in line with other semiconductor shares, but should “grow dramatically” in coming years.

Eminence Capital founder and chief executive Ricky Sandler named California-based New Relic, a company that allows organisations to monitor IT infrastructure, as his best pick.

The $US4bn market cap company develops cloud-based software to help website and application owners track the performance of their services.

“Up until recently they had been losing share based on their transition to a new product platform in 2020 and 2021,” Mr Sandler said. “The stock trades at a big discount to its peers.”

Over five years, NextDC, JB Hi-Fi, TradeDesk, Nickel Mines and MinRes are among the best performers among the conference picks. Among the worst, based on current prices, are Coinbase, Ping An, Teladoc Health, Spotify and Megaport, which have tumbled more than 70 per cent since they were pitched in 2020 and 2021.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

AMP’s board must focus on breaking up and selling parts of the 173-year group in an orderly way, to avoid repeating “bad old habits” and making ill-fated acquisitions.

That’s the view of Samuel Terry Asset Management founder Fred Woollard who on Friday outed AMP as his top stock pick at the Sohn Hearts & Minds investment conference in Hobart.

“The sum of the parts are worth substantially more than its market capitalisation,” he said, delivering the value manager’s first presentation to the conference, which is in its seventh year.

Mr Woollard said AMP’s shares were worth at least $2 and up to $2.17 on his model, versus its current price of $1.285.

He outlined that asset sales meant AMP would soon have surplus cash of more than $2bn, it owned a profitable bank, wealth business in New Zealand while its platform business was worth about $1bn. Samuel Terry’s AMP model put the value of its three international minority stakes at least $685m or up to $1bn.

“AMP‘s mix of assets do not belong together. There are no synergies between an Australian and New Zealand wealth manager and a minority stake-owned Chinese pension manager,” Mr Woollard said. “Keeping these assets together is costing AMP shareholders lots of money. Shrinking and simplifying AMP should not be rushed, it should be done in an orderly and considerate (manner).”

While AMP was one of four local stocks among the best picks at the Sohn conference, it was international stocks – including those across laboratory services, semiconductors and retail – that dominated the top picks.

Cooper Investors’ founder and investment chief Peter Cooper named Eurofins at his top pick for this year. The Luxembourg-headquartered group provides lab testing and support services to the pharmaceutical, food, environmental industries, among others.

“One of the attributes of the service is it’s really cheap,” Mr Cooper said. He noted Eurofins conducted 450 million tests per annum at a cost of about $15 per test for things such as food safety.

“Every year in this industry of testing, volumes are going up 5 per cent a year,” he said.

“It’s a terrific dynamic in a mission-critical product.”

Peter Cooper at Sohn Hearts & Minds Investment Leaders Conference in Hobart.
Peter Cooper at Sohn Hearts & Minds Investment Leaders Conference in Hobart.

Mr Cooper – whose firm manages $10.5bn – also highlighted Eurofins was delivering returns of 26 per cent per year for shareholders, surpassing returns of local stocks CSL and Macquarie Group.

“We think this thing’s worth €100 ($155) a share,” he said. Eurofins last traded at €66.50.

Claremont Global portfolio manager Bob Desmond picked sportswear giant Nike as his top pick. Just buy it, he quipped.

He said the company was “hoovering up data” that allowed it to innovate and deliver the right product to consumers, and had targeted having 60 per cent of sales made direct to consumers by 2025. Mr Desmond estimated Nike would get a 100 basis point tailwind from bypassing retailers.

The Sohn conference, held annually, had before Friday’s event made more than $40m in collective donations to medical research. It applies the stock picks made by fund managers in an investment portfolio. The listed fund’s latest performance update noted 8.3 per cent returns per annum since inception in November 2018, but it cited “disappointing” underperformance in October. Among its top 10 holdings are Alphabet, BHP, Visa and Zillow.

Tribeca Investment Partners portfolio manager Jun Bei Liu opted for a Chinese retail stock for her best pick. China Duty Free Group – the biggest duty free operator in the world – offered a “phenomenal opportunity” due to an expected “explosion of (Chinese) tourist numbers” in coming years as the pandemic receded, she said. Ms Liu noted growth would be delivered as the company pursued geographic expansion.

Tribeca Investment Partners portfolio manager Jun Bei Liu opted for a Chinese retail stock for her best pick. Picture: Jane Dempster
Tribeca Investment Partners portfolio manager Jun Bei Liu opted for a Chinese retail stock for her best pick. Picture: Jane Dempster

Munro Partners founder and investment chief Nick Griffin highlighted Dutch-listed company ASML as his stock pick.

ASML produces lithography tools for the production of semiconductors and Mr Griffin said the group was “a monopoly” in the high-end part of the market selling its products to companies including Samsung and Intel.

“We see ASML’s (earnings-per-share) growing from €14 today to €41 by 2025 … we expect their earnings to accelerate,” Mr Griffin said, noting the stock had fallen in line with other semiconductor shares, but should “grow dramatically” in coming years.

Eminence Capital founder and chief executive Ricky Sandler named California-based New Relic, a company that allows organisations to monitor IT infrastructure, as his best pick.

The $US4bn market cap company develops cloud-based software to help website and application owners track the performance of their services.

“Up until recently they had been losing share based on their transition to a new product platform in 2020 and 2021,” Mr Sandler said. “The stock trades at a big discount to its peers.”

Over five years, NextDC, JB Hi-Fi, TradeDesk, Nickel Mines and MinRes are among the best performers among the conference picks. Among the worst, based on current prices, are Coinbase, Ping An, Teladoc Health, Spotify and Megaport, which have tumbled more than 70 per cent since they were pitched in 2020 and 2021.

This article was originally posted by The Australian here.

Licensed by Copyright Agency. You must not copy this work without permission.

Disclaimer: This material has been prepared by The Australian, published on Nov 18, 2022. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
March 12, 2023

Jun Bei Liu is not giving up on the China reopening theme

Tribeca’s Jun Bei Liu says China’s reopening is only getting started, and names five ASX stocks set to benefit.

Read More
January 18, 2023

Claremont Global: Investment Case for Nike

Equity Mates are joined by Head of Claremont Global Bob Desmond to discuss his 2022 conference pick, Nike. In the episode Bob unpacks the key metrics, the bull case and the bear case for Nike.

Read More
January 5, 2023

Why Transurban will always be one step ahead of inflation

Loathed by motorists, but loved by investors. Transurban came under focus when Catherine Allfrey nominated the roads operator as her top pick at the recent Sohn Hearts & Minds Conference.

Read More
November 18, 2022

Behind the mega-themes shaping top stockpickers

These are the mega-themes the smartest minds in the market are now firmly getting behind which they believe can help them deliver outsized profits.

Read More
November 18, 2022

Don’t rush to invest yet, fund manager tells Sohn event

Fund manager turned anti-corruption campaigner Bill Browder is advising investors to hang on to their cash until central banks stop raising interest rates and the cost of living starts to come down.

Read More
November 18, 2022

Fundies and billionaires party in Hobart

Two hundred of Australia’s best and brightest money managers, bankers and entrepreneurs toasted the seventh Sohn Hearts and Minds conference at David Walsh’s MONA.

Read More
November 18, 2022

Hearts racing: Rich listers rendezvous for speed-dating style stock picking

A room filled with 700 of the country’s financial luminaries and billionaires is a difficult place to pitch an investment idea but it’s a great place to raise money for charity.

Read More
November 18, 2022

How MONA’s David Walsh shocked our top stock pickers

Professional gambler and arts impresario David Walsh had a brutal message for successful top money managers – you may just be lucky.

Read More
November 18, 2022

Why Sohn’s top stock pickers want investors to play it safe

Top global money managers are telling investors to steer clear of companies that don’t make money and invest instead in unloved but profitable businesses.

Read More
November 17, 2022

Five years on, what are the best Sohn stock picks to date?

Some of the top fund managers in the country will on Friday pitch their best investment ideas to the Sohn Hearts & Minds conference.

Read More
November 17, 2022

Low debt counts for everything, says Perpetual’s Aboud

Perpetual’s top stock picker Anthony Aboud makes his money running against the crowd and this is why property trusts like Charter Hall are sitting right the top his list right now.

Read More
November 17, 2022

Perpetual’s Aboud says bet on balance sheets in turbulent markets

Perpetual’s Anthony Aboud says companies with strong balance sheets will finally be rewarded for their discipline in a time of global market upheaval.

Read More
November 16, 2022

How Gerry Cardinale of RedBird Capital tries to double his money investing in sport

The owner of AC Milan and a host of other soccer, cricket, baseball and ice hockey assets is trying to double his money in the ‘resilient’ asset class.

Read More
November 14, 2022

Think outside the box for green investment opportunities

James Miller, Portfolio Manager at Firetrail Investments, believes investors need to stop seeing the global decarbonisation push as a risk – and start seeing it as an opportunity.

Read More
November 14, 2022

Tim Carleton is backing the Aussie dream all the way

Carleton’s conviction will be on full display on Friday when he makes his third appearance at the Sohn Hearts & Minds Conference, where stock-pickers share their best ideas in the name of medical research.

Read More